Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2022

View Archived Issues

New inhibitors of G12C mutant KRAS protein identified at Amgen

Calithera Biosciences presents new L-amino acid oxidase inhibitors

Medshine Discovery patents Janus kinase inhibitors

Novel CAR-NK cells targeting CD33 show promise for AML

New compounds targeting the estrogen receptor divulged by Sanofi

Korea University Research and Business Foundation presents new apoptosis inducers

Diabetic foot ulcers hold clues to tumor suppression

CCL22-derived peptides as vaccines for cancer immunotherapy

Large animal model of USH3 disease generated by zygote injection and guide RNAs

miR30e-5p is a predictive biomarker of relapse in myasthenia gravis

MuSK-CAARTs demonstrate promising safety and activity in models of MuSK myasthenia gravis

AMP vaccine boosting enhances TCR-T cell therapy in mice with solid tumors

SOM signs licensing agreement with University of Minnesota to support muscular dystrophy work

SHP-2 inhibitor NSC-87877 ameliorates clinical symptoms of MuSK-induced myasthenia gravis

Celmatix identifies AMHR2 agonist to prevent premature menopause after chemotherapy

BioAge develops small-molecule NLRP3 inhibitors for inflammatory and age-related diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...